Guangfeng WANG

Person

Suzhou, CN

People

Patents Grantslast 30 patents

Information Patent Grant
Method for treating cancer by combination of IAP inhibitor and modu...
- Patent number 12,186,304
- Issue date Jan 7, 2025
- ASCENTAGE PHARMA (SUZHOU) CO., LTD.
- Dajun Yang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of BCL-2/BCL-XL inhibitors and chemotherapeutic agent a...
- Patent number 12,083,136
- Issue date Sep 10, 2024
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun Yang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synergistic antitumor effect of Bcl-2 inhibitor combined with ritux...
- Patent number 11,554,127
- Issue date Jan 17, 2023
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun Yang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination product of Bcl-2 inhibitor and chemotherapeutic agent a...
- Patent number 11,491,167
- Issue date Nov 8, 2022
- ASCENTAGE PHARMA (SUZHOU) CO., LTD.
- Dajun Yang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination product of Bcl-2 inhibitor or Bcl-2/Bcl-xL dual inhibit...
- Patent number 11,478,470
- Issue date Oct 25, 2022
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun Yang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating cancer by combination of FAK/ALK/ROS1 inhibitor...
- Patent number 11,478,477
- Issue date Oct 25, 2022
- ASCENTAGE PHARMA (SUZHOU) CO., LTD.
- Dajun Yang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMBINATION OF BCL-2/BCL-XL INHIBITORS AND CHEMOTHERAPEUTIC AGENT A...
- Publication number 20240390401
- Publication date Nov 28, 2024
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun YANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A PHARMACEUTICAL COMPOSITION AND USE THEREOF FOR TREATMENT OF CANCER
- Publication number 20230381176
- Publication date Nov 30, 2023
- Ascentage Pharma (Suzhou) Co., Ltd.
- Yifan Zhai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATION AND USE THEREOF
- Publication number 20220323465
- Publication date Oct 13, 2022
- Ascentage Pharma (Suzhou) Co., Ltd.
- Yifan ZHAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNERGISTIC ANTITUMOR EFFECT OF BCL-2 INHIBITOR COMBINED WITH RITUX...
- Publication number 20210361678
- Publication date Nov 25, 2021
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun YANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR TREATING CANCER BY COMBINATION OF IAP INHIBITOR AND MODU...
- Publication number 20210330642
- Publication date Oct 28, 2021
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun YANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR TREATING CANCER BY COMBINATION OF FAK/ALK/ROSI INHIBITOR...
- Publication number 20210330669
- Publication date Oct 28, 2021
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun YANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION PRODUCT OF BCL-2 INHIBITOR AND CHEMOTHERAPEUTIC AGENT A...
- Publication number 20210137949
- Publication date May 13, 2021
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun YANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF BCL-2/BCL-XL INHIBITORS AND CHEMOTHERAPEUTIC AGENT A...
- Publication number 20210060039
- Publication date Mar 4, 2021
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun YANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION PRODUCT OF BCL-2 INHIBITOR OR BCL-2/BCL-XL DUAL INHIBIT...
- Publication number 20200222393
- Publication date Jul 16, 2020
- Ascentage Pharma (Suzhou) Co., Ltd.
- Dajun YANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Guangfeng WANG

Person

Patents Grantslast 30 patents

Method for treating cancer by combination of IAP inhibitor and modu...

Combination of BCL-2/BCL-XL inhibitors and chemotherapeutic agent a...

Synergistic antitumor effect of Bcl-2 inhibitor combined with ritux...

Combination product of Bcl-2 inhibitor and chemotherapeutic agent a...

Combination product of Bcl-2 inhibitor or Bcl-2/Bcl-xL dual inhibit...

Method for treating cancer by combination of FAK/ALK/ROS1 inhibitor...

Patents Applicationslast 30 patents

COMBINATION OF BCL-2/BCL-XL INHIBITORS AND CHEMOTHERAPEUTIC AGENT A...

A PHARMACEUTICAL COMPOSITION AND USE THEREOF FOR TREATMENT OF CANCER

PHARMACEUTICAL COMBINATION AND USE THEREOF

SYNERGISTIC ANTITUMOR EFFECT OF BCL-2 INHIBITOR COMBINED WITH RITUX...

METHOD FOR TREATING CANCER BY COMBINATION OF IAP INHIBITOR AND MODU...

METHOD FOR TREATING CANCER BY COMBINATION OF FAK/ALK/ROSI INHIBITOR...

COMBINATION PRODUCT OF BCL-2 INHIBITOR AND CHEMOTHERAPEUTIC AGENT A...

COMBINATION OF BCL-2/BCL-XL INHIBITORS AND CHEMOTHERAPEUTIC AGENT A...

COMBINATION PRODUCT OF BCL-2 INHIBITOR OR BCL-2/BCL-XL DUAL INHIBIT...